2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
INACTIVE
Global HQ
San Sebastian, Spain
Countries of investment
  • Spain
  • Portugal
  • France
  • Germany
  • Israel
  • United States
Investment stages
  • Seed
  • Series A
Industries
  • Deeptech
  • Life Sciences
  • Digital Tech
  • Venture Debt
  • Industrial Tech
About
Inveready is one of Spain's leading alternative asset managers backing innovative companies across their entire lifecycle. Their focus spans digital technologies, life sciences, venture debt, infrastructure, and public market strategies. The firm combines €1.2B+ AUM across 35+ funds with offices in San Sebastián, Barcelona, and Madrid to support founders from seed through public listings.
Min check size
$250K
Max check size
$4M
Fund size
NPS

Investment Thesis

Inveready is a multi-strategy alternative asset manager deploying capital across technology venture, life sciences, venture debt, and public equity. They invest in Spanish and European companies throughout their lifecycle from seed to mature stages, with specialized vehicles for each asset class. The firm differentiates itself through 360º financing solutions, deep Spanish ecosystem coverage, and the highest-return alternative asset platform in the Spanish market.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Founded by Josep M. Echarri and partners, Inveready’s team combines venture and private equity expertise, investing across multiple asset classes with strong experience in scaling technology and healthcare companies.

Inveready Contacts Information

Primary contact

Secondary contact

Team

Josep Maria Echarri - Founding Partner

Roger Piqué - Founding Partner

Ignacio Fonts - Managing Director

Sarah Bel - Partner Biotech

Portfolio

Feedzai

Gigas

Oncovision

Atlas Molecular Pharma

Pharmacelera

Hospital Capilar

Grupo Uvesco

Reveni

Geniova

Caplena

Wikifarmer

3Scale

Alda Hotels

Schaman

Scaleup Finance

Nanoligent

Medibiofarma

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp